ENPP2 and cancer: When inflammation is not resolved, chronic activation of the ATX–LPA-inflammatory cycle becomes maladaptive [7,9] in conditions such as pulmonary fibrosis, cirrhosis, rheumatoid arthritis, inflammatory bowel disease and cancers [10,11].